Abstract:A pandemic of acute respiratory infection, which was specified as coronavirus disease 2019, was instigated by a different strain of the virulent coronavirus SARS-CoV-2 that first appeared in late 2019. Since viral infections spread fast and there is presently no effective treatment, the use of plants with a long history of use in treating these infections has been explored regularly. The pandemic of coronavirus disease 2019 (COVID-19) has brought to light the dearth of medications with approval to treat acute viral illnesses. Because of this, the illness had a high fatality rate. The mortality rate was initially quite high and varied according to the patient's geographic location. For instance, among Chinese patients, the rate was 3·6%, whereas 1·5% of COVID-19-related deaths were documented outside of China. As of 2020, India has a 1.4% case fatality rate (CFR) of COVID-19 mortality, compared to 2.8% in Brazil and 1.8% in the USA. Many studies are being conducted to create pharmaceutical compounds specifically targeting important SARS-CoV-2 proteins. Several drug discovery initiatives are being undertaken to find powerful inhibitors by combining biochemical assay and computer-aided drug design techniques. Although plant-derived compounds have not had much success in the dominion of antivirals, plants are, however, believed to be a limitless supply of medications for a variety of diseases and clinical conditions. The scientific foundation required for developing novel natural source medications is provided by the chemical characterization and analysis of plant components. Most viral infections treated by ethnobotanical applications and historical literature on ayurveda, and traditional medicine are generally attributed to phytochemicals, which are compounds derived from medicinal plants. In this review, we have described the application of vascular plant-derived chemicals, such as tannins, polyphenols, alkaloids, and flavonoids, as antivirals, especially for managing COVID-19. This article discusses novel bioactive compounds and their molecular structures that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as prospective candidates for anti-coronavirus disease drugs. Moreover, to confirm the effectiveness of the phytochemicals that have demonstrated antiviral activity, clinical trials would need to be conducted in addition to the preclinical research that has already been done. To ensure spectacular findings, more applications of the compound would need to be studied to fully understand the effects of those phytochemicals whose clinical usefulness has already been established.

The effectiveness of common household spices and herbs in combating the COVID-19: A review based on experimental and virtual screening

In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19

Ayurvedic and Chinese Herbs against Coronaviruses

Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review

Plant-Derived Natural Compounds as an Emerging Antiviral in Combating COVID-19

The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection

A critical review on phytochemicals as antiviral medications for SARS-CoV-2 virus infection

So you have a management information system: what's next?

Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review

Current strategies against COVID-19

Histochemistry and the structure of the skin of a murrel, Channa striata (Bloch, 1797) (Channiformes, Channidae). I. Epidermis.

In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection

Target-Based in Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2

Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection

A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19

Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection

Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study

Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies

Edible and Herbal Plants for the Prevention and Management of COVID-19

Plant‐derived compounds as potential leads for new drug development targeting COVID‐19